DCM
EGRX

DGS Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

DGS Capital Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-71,728
Closed -$268K – 336
2024
Q3 		$268K Buy
71,728
+22,239
+45% +$83K 0.07% 235
2024
Q2 		$277K Sell
49,489
-12,455
-20% -$69.7K 0.08% 216
2024
Q1 		$325K Buy
61,944
+50,525
+442% +$265K 0.09% 197
2023
Q4 		$59.7K Buy
+11,419
New +$59.7K 0.02% 245